Drug Trial Radar · NCT06691828
Absolute Bioavailability, Absorption, Metabolism, Excretion, and Mass Balance Study of [14C] NX-5948
Last checked: Nov 19, 2026Latest source record: Mar 12, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
8
Actual
Start
Nov 1, 2024
Primary completion
Nov 28, 2024
Study completion Dec 5, 2024
Sponsor
- Lead sponsor
- Nurix Therapeutics, Inc.Industry
- Sponsor type
- Industry
- First posted
- Nov 15, 2024
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- Male only, from 19 years, up to 55 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
This is a Phase 1, 2-period, open-label, single-dose, fixed-sequence study to assess the absolute bioavailability, absorption, metabolism, excretion, and mass balance of \[14C\]-NX-5948. Period 1 will analyze PD (pharmacodynamics) and exploratory biomarkers. Period 2 will analyze total radioactivity and metabolite profiling.
Conditions
- Healthy Volunteer
Interventions
NX-5948Drug
NX-5948 will be given once by IV and then given once by mouth.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Characterize Area Under the Curve (AUC0-inf), Half-life (T1/2) after IV dosing of NX-5948Time frame: 9 weeks
- Evaluation of metabolite after oral dosing with [14C]-NX-5948Time frame: 9 weeks
- Assessment of bioavailability with oral dosing of NX-5948Time frame: 9 weeks
- Assessment of total radioactivity after oral dosing with NX-5948Time frame: 9 weeks
- Assessment of whole blood to plasma ratio for TRA after oral dosing with NX-5948Time frame: 9 weeks
- Characterize the Clearance (CL) after IV dosing of NX-5948Time frame: 9 weeks
- Characterize the Volume of distribution (Vz) after IV dosing of NX-5948Time frame: 9 weeks
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Celerion
Lincoln, Nebraska
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.